Browse All

Current Filters

CLEAR FILTER x

TITLE

Ocrelizumab Subcutaneous Administration: Further Characterization of the Benefit–Risk Profile from the OCARINA II Study and Patient Preferences

Author:Newsome, Scott   Goldstick, Lawrence   Selmaj, Krzysztof   Krzystanek, Ewa   Zecevic, Dusanka   Figueiredo, Catarina   Clinch, Susanne   Giacobino, Caroline   Azmi, Jay   Centonze, Diego   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.003  

Author Institution:Johns Hopkins University School of Medicine, Baltimore, MD, USA, Baltimore, MD  Department of Neurology and Rehabilitation Waddell Center for Multiple Sclerosis, University of Cincinnati, College of Medicine, Cincinnati, OH, USA, Cincinnati, OH  Centrum Neurologii, Lódz, Poland, Lódz, Poland  Department of Neurology, School of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland, Katowice, Poland  F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland  Roche Products Ltd, Welwyn Garden City, UK, Welwyn Garden City, United Kingdom  Unit of Neurology, IRCCS Neuromed, Pozzilli (IS), Italy, Rome, Italy